Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

Nature Genetics

Volumn 43, Issue 7, 2011, Pages 699-705

  Höglinger, Günter U ^a   Melhem, Nadine M ^b   Dickson, Dennis W ^c   Sleiman, Patrick M A ^d   Wang, Li San ^e   Klei, Lambertus ^b   Rademakers, Rosa ^c   De Silva, Rohan ^f   Litvan, Irene ^g   Riley, David E ^h   Van Swieten, John C ⁱ   Heutink, Peter ^j   Wszolek, Zbigniew K ^k   Uitti, Ryan J ^k   Vandrovcova, Jana ^f   Hurtig, Howard I ^l   Gross, Rachel G ^l   Maetzler, Walter ^m,n   Goldwurm, Stefano ^o   Tolosa, Eduardo ^p   Borroni, Barbara ^q   Pastor, Pau ^r,s,t   Cantwell, Laura B ^e   Han, Mi Ryung ^e   Dillman, Allissa ^u   Van Der Brug, Marcel P ^v   Gibbs, J Raphael ^f,u   Cookson, Mark R ^u   Hernandez, Dena G ^f,u   Singleton, Andrew B ^u   Farrer, Matthew J ^w   Yu, Chang En ^x,y   Golbe, Lawrence I ^z   Revesz, Tamas ^aa   Hardy, John ^f   Lees, Andrew J ^f,aa   Devlin, Bernie ^b   Hakonarson, Hakon ^d   Müller, Ulrich ^ab   Schellenberg, Gerard D ^e   Albin, Roger L ^ac,ad   Alonso, Elena ^r,s   Antonini, Angelo ^o,ae   Apfelbacher, Manuela ^af   Arnold, Steven E ^e   Avila, Jesus ^ag   Beach, Thomas G ^ah   Beecher, Sherry ^e   Berg, Daniela ^ai   Bird, Thomas D ^y   Bogdanovic, Nenad ^aj   Boon, Agnita J W ⁱ   Bordelon, Yvette ^ak   Brice, Alexis ^al,am,an   Budka, Herbert ^ao   Canesi, Margherita ^o   Chiu, Wang Zheng ⁱ   Cilia, Roberto ^o   Colosimo, Carlo ^ap   De Deyn, Peter P ^aq   De Yebenes, Justo Garcãa ^ar   Kaat, Laura Donker ⁱ   Duara, Ranjan ^as   Durr, Alexandra ^al,am,an   Engelborghs, Sebastiaan ^aq   Fabbrini, Giovanni ^ap   Finch, Nicole A ^c   Flook, Robyn ^at   Frosch, Matthew P ^au   Gaig, Carles ^p   Galasko, Douglas R ^av   Gasser, Thomas ^ai   Gearing, Marla ^aw   Geller, Evan T ^e   Ghetti, Bernardino ^ax   Graff Radford, Neill R ^k   Grossman, Murray ^l   Hall, Deborah A ^ay   Hazrati, Lili Naz ^az   Höllerhage, Matthias ^a   Jankovic, Joseph ^ba   Juncos, Jorge L ^aw   Karydas, Anna ^bb   Kretzschmar, Hans A ^bc   Leber, Isabelle ^al,am,an   Lee, Virginia M ^e   Lieberman, Andrew P ^ac   Lyons, Kelly E ^bd   Mariani, Claudio ^o   Masliah, Eliezer ^av,be   Massey, Luke A ^f   McLean, Catriona A ^bf   Meucci, Nicoletta ^o   Miller, Bruce L ^bb   Mollenhauer, Brit ^bg   Möller, Jens C ^a   Morris, Huw R ^bh   Morris, Chris ^bi   O'Sullivan, Sean S ^f   Oertel, Wolfgang H ^a   Ottaviani, Donatella ^ap   Padovani, Alessandro ^q   Pahwa, Rajesh ^bd   Pezzoli, Gianni ^o   Pickering Brown, Stuart ^bj   Poewe, Werner ^bk   Rabano, Alberto ^bl   Rajput, Alex ^bm   Reich, Stephen G ^bn   Respondek, Gesine ^a   Roeber, Sigrun ^bc   Rohrer, Jonathan D ^aa   Ross, Owen A ^c   Rossor, Martin N ^aa   Sacilotto, Giorgio ^o   Seeley, William W ^bb   Seppi, Klaus ^bk   Silveira Moriyama, Laura ^f   Spina, Salvatore ^ax   Srulijes, Karin ^ai   St George Hyslop, Peter ^az,bo   Stamelou, Maria ^a   Standaert, David G ^bp   Tesei, Silvana ^o   Tourtellotte, Wallace W ^bq   Trenkwalder, Claudia ^bg   Troakes, Claire ^br   Trojanowski, John Q ^e   Troncoso, Juan C ^bs   Van Deerlin, Vivianna M ^e   Vonsattel, Jean Paul G ^bt   Wenning, Gregor K ^bk   White, Charles L ^bu   Winter, Pia ^ab   Zarow, Chris ^bv   Zecchinelli, Anna L ^o   more..

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g University of Louisville School of Medicine   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^k MAYO CLINIC   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m UNIVERSITY OF TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF TÜBINGEN   (Germany)

^o PARKINSON INSTITUTE   (Italy)

^p UNIVERSITY OF BARCELONA   (Spain)

^q UNIVERSITY OF BRESCIA   (Italy)

^r INSTITUTO DE SALUD CARLOS III   (Spain)

^s UNIVERSITY OF NAVARRA   (Spain)

^t UNIVERSITY CLINIC OF NAVARRA   (Spain)

^u NATIONAL INSTITUTE ON AGING   (United States)

^v SCRIPPS RESEARCH INSTITUTE   (United States)

^w UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^x UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^y VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^z ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^aa UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ab JUSTUS LIEBIG UNIVERSITY   (Germany)

^ac UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^ad VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^ae IRCCS SAN CAMILLO HOSPITAL   (Italy)

^af UNIVERSITY OF WÜRZBURG   (Germany)

^ag UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^ah SUN HEALTH RESEARCH INSTITUTE   (United States)

^ai GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^aj KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ak UNIVERSITY OF CALIFORNIA   (United States)

^al INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^am INSERM   (France)

^an CNRS   (France)

^ao MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ap SAPIENZA UNIVERSITY OF ROME   (Italy)

^aq UNIVERSITY OF ANTWERP   (Belgium)

^ar HOSPITAL RAMÓN Y CAJAL   (Spain)

^as MOUNT SINAI MEDICAL CENTER   (United States)

^at FLINDERS UNIVERSITY   (Australia)

^au MASSACHUSETTS GENERAL HOSPITAL   (United States)

^av UNIVERSITY OF CALIFORNIA   (United States)

^aw EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ax INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ay RUSH MEDICAL COLLEGE   (United States)

^az UNIVERSITY OF TORONTO   (Canada)

^ba BAYLOR COLLEGE OF MEDICINE   (United States)

^bb UNIVERSITY OF CALIFORNIA   (United States)

^bc UNIVERSITY OF MUNICH   (Germany)

^bd UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^be UNIVERSITY OF CALIFORNIA   (United States)

^bf FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^bg UNIVERSITY OF GÖTTINGEN   (Germany)

^bh CARDIFF UNIVERSITY   (United Kingdom)

^bi NEWCASTLE UNIVERSITY   (United Kingdom)

^bj UNIVERSITY OF MANCHESTER   (United Kingdom)

^bk INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^bl CSIC   (Spain)

^bm ROYAL UNIVERSITY HOSPITAL   (Canada)

^bn UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^bo UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bp The University of Alabama at Birmingham   (United States)

^bq VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^br KING'S COLLEGE LONDON   (United Kingdom)

^bs JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bt NewYork Presbyterian Hospital   (United States)

^bu UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^bv UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

CELL MEMBRANE; CELL VACUOLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; RISK; TAUOPATHY; UNFOLDED PROTEIN RESPONSE;

EID: 79959689333     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.859     Document Type: Conference Paper

References (47)

1. Hoppitt, T. et al. A systematic review of the incidence and prevalence of long-term neurological conditions in the UK. Neuroepidemiology 36, 19-28 (2011).
2. Litvan, I. Update on progressive supranuclear palsy. Curr. Neurol. Neurosci. Rep. 4, 296-302 (2004). (Pubitemid 39023099)
3. Dickson, D.W., Rademakers, R. & Hutton, M.L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 17, 74-82 (2007).
4. Stamelou, M. et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain 133, 1578-1590 (2010).
5. McKee, A.C. et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918-929 (2010).
6. Golbe, L.I. et al. Follow-up study of risk factors in progressive supranuclear palsy. Neurology 47, 148-154 (1996). (Pubitemid 26243876)
7. Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129-137 (2005).
8. Baker, M. et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711-715 (1999). (Pubitemid 29139987)
9. Cruchaga, C. et al. 5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration. Neurobiol. Dis. 33, 164-170 (2009).
10. Houlden, H. et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702-1706 (2001). (Pubitemid 32574570)
11. Sundar, P.D. et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum. Mol. Genet. 16, 295-306 (2007). (Pubitemid 46331216)
12. Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312 (2009).
13. Chanock, S.J. et al. Replicating genotype-phenotype associations. Nature 447, 655-660 (2007). (Pubitemid 46889722)
14. Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209-213 (2006). (Pubitemid 43177235)
15. Zody, M.C. et al. Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat. Genet. 40, 1076-1083 (2008).
16. Tian, C. et al. Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet. 4, e4 (2008).
17. Litvan, I. et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47, 1-9 (1996). (Pubitemid 26243849)
18. Osaki, Y. et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov. Disord. 19, 181-189 (2004). (Pubitemid 38312700)
19. Duffy, D.L. et al. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J. Invest. Dermatol. 130, 520-528 (2010).
20. Farrer, L.A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278, 1349-1356 (1997). (Pubitemid 27449696)
21. Rademakers, R. et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14, 3281-3292 (2005). (Pubitemid 41631302)
22. Caffrey, T.M., Joachim, C., Paracchini, S., Esiri, M.M. & Wade-Martins, R. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 15, 3529-3537 (2006). (Pubitemid 44884120)
23. Myers, A.J. et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25, 561-570 (2007).
24. Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093 (2009).
25. Lambert, J.C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099 (2009).
26. Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. J. Am. Med. Assoc. 303, 1832-1840 (2010).
27. Naj, A.C. et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43, 436-441 (2011).
28. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435 (2011).
29. Nalls, M.A. et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641-649 (2011).
30. Unterberger, U. et al. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348-357 (2006). (Pubitemid 44264832)
31. Hoozemans, J.J.M. et al. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241-1251 (2009).
32. Hoozemans, J.J. et al. Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354, 707-711 (2007). (Pubitemid 46186242)
33. Jahn, R. & Scheller, R.H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7, 631-643 (2006).
34. Wendler, F. & Tooze, S. Syntaxin 6: the promiscuous behaviour of a SNARE protein. Traffic 2, 606-611 (2001). (Pubitemid 32825699)
35. Montague, P., McCallion, A.S., Davies, R.W. & Griffiths, I.R. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev. Neurosci. 28, 479-487 (2006). (Pubitemid 44532975)
36. Scheper, W. & Hoozemans, J.J.M. Endoplasmic reticulum protein quality control in neurodegenerative disease: the good, the bad and the therapy. Curr. Med. Chem. 16, 615-626 (2009).
37. Paschen, W. & Mengesdorf, T. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease-therapeutic potential. Pharmacol. Ther. 108, 362-375 (2005). (Pubitemid 41693766)
38. Hauw, J.J. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015-2019 (1994).
39. Dickson, D.W. et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61, 935-946 (2002). (Pubitemid 35278715)
40. Lee, A.B., Luca, D., Klei, L., Devlin, B. & Roeder, K. Discovering genetic ancestry using spectral graph theory. Genet. Epidemiol. 34, 51-59 (2010).
41. Crossett, A. et al. Using ancestry matching to combine family-based and unrelated samples for genome-wide association studies. Stat. Med. 29, 2932-2945 (2010).
42. Tian, C., Plenge, R.M., Ransom, M., Lee, A. & Villoslada, P. Analysis and application of European genetic substructure using 300K SNP information. PLoS Genet. 4, e4 (2008).
43. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006). (Pubitemid 44141658)
44. Luca, D. et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am. J. Hum. Genet. 82, 453-463 (2008).
45. Wu, J., Devlin, B., Ringquist, S., Trucco, M. & Roeder, K. Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol 34, 275-285 (2010).
46. Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010).
47. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)